{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:34:33Z","timestamp":1778261673596,"version":"3.51.4"},"reference-count":44,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>We conducted a randomized study analyzing the impact of darbepoetin alfa (DA) administration with or without intravenous (i.v.) iron on erythroid recovery after autologous hematopoietic cell transplantation (HCT). Patients were randomized between no DA (Arm 1), DA 300 \u03bcg every 2 weeks starting on Day 28 after HCT (Arm 2), or DA plus i.v. iron 200 mg on Days 28, 42, and 56 (Arm 3). The proportion achieving complete hemoglobin (Hb) response within 18 weeks (primary end point) was 21% in Arm 1 (<jats:italic>n<\/jats:italic>\u2009=\u200924), 79% in Arm 2 (<jats:italic>n<\/jats:italic>\u2009=\u200925), and 100% in Arm 3 (<jats:italic>n<\/jats:italic>\u2009=\u200923; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Erythropoietic response was shown to be significantly higher in Arm 3 (<jats:italic>n<\/jats:italic>\u2009=\u200946) than in Arm 2 (<jats:italic>n<\/jats:italic>\u2009=\u200950; <jats:italic>P<\/jats:italic>\u2009=\u20090.008), resulting in lower DA use, reduced drug costs, and improved quality of life scores, but the effect on transfusions was not significant. In multivariate analysis, DA administration (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), i.v. iron administration (<jats:italic>P<\/jats:italic>\u2009=\u20090.0010), high baseline Hb (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), and low baseline creatinine (<jats:italic>P<\/jats:italic>\u2009=\u20090.0458) were independently associated with faster achievement of complete Hb response. In conclusion, DA is highly effective to ensure full erythroid reconstitution after autologous HCT when started on Day 28 post\u2010transplant. I.v. iron sucrose further improves erythroid recovery. Am. J. Hematol. 88:990\u2013996, 2013. \u00a9 2013 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ajh.23552","type":"journal-article","created":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T06:14:52Z","timestamp":1374473692000},"page":"990-996","source":"Crossref","is-referenced-by-count":28,"title":["Darbepoetin\u2010alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial"],"prefix":"10.1002","volume":"88","author":[{"given":"Yves","family":"Beguin","sequence":"first","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"},{"name":"Giga\u2010Research University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"Clinical Hematology Acute Leukemia &amp; Stem Cell Transplantation Unit University Hospital Gasthuisberg Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"De Prijck","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHR la Citadelle Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Schots","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology and Stem Cell Laboratory Universitair Ziekenhuis Brussel Brussel Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Seidel","sequence":"additional","affiliation":[{"name":"Department of Statistics University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Bonnet","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoutar","family":"Hafraoui","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Willems","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetan","family":"Vanstraelen","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Servais","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"},{"name":"Giga\u2010Research University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Jaspers","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Fillet","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"},{"name":"Giga\u2010Research University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Baron","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Hematology CHU of Li\u00e8ge University of Li\u00e8ge Li\u00e8ge Belgium"},{"name":"Giga\u2010Research University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"1076","article-title":"Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation","volume":"83","author":"Beguin Y","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109488"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.10.014"},{"key":"e_1_2_6_5_1","first-page":"285","article-title":"Dynamics of erythropoietic recovery after bone marrow transplantation: Role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants","volume":"11","author":"Beguin Y","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.4.868.868"},{"key":"e_1_2_6_7_1","first-page":"5566","article-title":"Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment","volume":"9","author":"Baron F","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_8_1","first-page":"219","article-title":"Use of granulocyte\u2010macrophage colony\u2010stimulating factor and erythropoietin in combination after autologous marrow transplantation","volume":"11","author":"Pene R","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.10.3327.3327"},{"key":"e_1_2_6_10_1","first-page":"403","article-title":"Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: Effect on erythroid repopulation in autologous versus allogeneic transplants","volume":"13","author":"Locatelli F","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_11_1","first-page":"929","article-title":"Pilot trial of combined administration of erythropoietin and granulocyte colony\u2010stimulating factor to children undergoing allogeneic bone marrow transplantation","volume":"14","author":"Locatelli F","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_12_1","first-page":"527","article-title":"Combination therapy with G\u2010CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: A randomized trial","volume":"17","author":"Vannucchi AM","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_13_1","first-page":"13","article-title":"The Functional Assessment of Cancer Therapy\u2010Anemia (FACT\u2010An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue","volume":"34","author":"Cella D","year":"1997","journal-title":"Semin Hematol"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.2.637"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(02)00795-6"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200212270-00008"},{"key":"e_1_2_6_17_1","first-page":"718","article-title":"Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment","volume":"88","author":"Baron F","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_6_18_1","first-page":"1269","article-title":"Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation","volume":"90","author":"Vanstraelen G","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04556.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404431"},{"key":"e_1_2_6_21_1","first-page":"1209","article-title":"Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients","volume":"87","author":"Beguin Y","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_6_22_1","first-page":"434","article-title":"Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy","volume":"81","author":"Cazzola M","year":"1996","journal-title":"Haematologica"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(05)80284-9"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04886.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.10.2823.2823"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1502.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2139.2139_2139_2145"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.10.3286.410k29_3286_3293"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.119"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-2-231"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404562"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2051"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.4620"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-011-1072-3"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.3644"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.3219"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.9031"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21779"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00924.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23354"},{"key":"e_1_2_6_41_1","first-page":"20","article-title":"The impact of epoetin alfa on quality of life during cancer chemotherapy: A fresh look at an old problem","volume":"34","author":"Glaspy J","year":"1997","journal-title":"Semin Hematol"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3412"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60502-X"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-300541"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604408"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23552","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23552","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.23552","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T08:57:15Z","timestamp":1693213035000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.23552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1002\/ajh.23552"],"URL":"https:\/\/doi.org\/10.1002\/ajh.23552","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]}}}